申请人:SmithKline Corporation
公开号:US03956325A1
公开(公告)日:1976-05-11
The compounds of this invention are 5-heterocyclic-1,2,3,6-tetrahydro-4(5H)-pyrimidinethiones which have pharmacological activity, in particular gastric acid secretion inhibitory activity, and 5-heterocyclic-1,2,3,6-tetrahydro-4(5H)-pyrimidinones which are intermediates in the preparation therefor.
本发明的化合物是具有药理活性的5-杂环-1,2,3,6-四氢-4(5H)-嘧啶硫酮,特别是具有胃酸分泌抑制活性的化合物,并且是其制备中间体的5-杂环-1,2,3,6-四氢-4(5H)-嘧啶酮。